Stocks
Interpace Biosciences, Inc.IDXG
OIDHealthcareBiotechnology$6.50
Price as of · delayed, not real-time
A molecular diagnostics company focused on developing and commercializing genomic tests for cancer and rare diseases. Its lead products include tests for thyroid cancer risk assessment and pancreatic cysts, which are marketed to pathologists and clinicians. Investors track the company for its niche position in precision oncology diagnostics and its efforts to expand reimbursement coverage.
52W Range: $0.81-$7.80
Congressional Interest in Interpace Biosciences, Inc. (IDXG)
No congressional trades have been disclosed for Interpace Biosciences, Inc. (IDXG) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading IDXG?
No congressional trades found for this stock.